{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:37:54Z","timestamp":1780054674138,"version":"3.54.0"},"reference-count":5,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,26]]},"DOI":"10.1515\/cclm-2017-0441","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T10:02:06Z","timestamp":1501581726000},"page":"e50-e52","source":"Crossref","is-referenced-by-count":1,"title":["Interference between ethosuximide and barbiturates in an immunochromatographic method"],"prefix":"10.1515","volume":"56","author":[{"given":"Paula","family":"San-Jos\u00e9","sequence":"first","affiliation":[{"name":"Clinical Laboratory , Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT , Universitat Aut\u00f2noma de Barcelona , Sabadell , Spain , Phone: +93.745.84.39, Fax: +93.716.20.04"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Cano-Corres","sequence":"additional","affiliation":[{"name":"Clinical Laboratory , Biochemistry Department , Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT , Universitat Aut\u00f2noma de Barcelona , Sabadell , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Aguadero","sequence":"additional","affiliation":[{"name":"Clinical Laboratory , Biochemistry Department , Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT , Universitat Aut\u00f2noma de Barcelona , Sabadell , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Miralles-Albors","sequence":"additional","affiliation":[{"name":"Pharmacy Department , Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT , Universitat Aut\u00f2noma de Barcelona , Sabadell , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Berlanga-Escalera","sequence":"additional","affiliation":[{"name":"Clinical Laboratory , Biochemistry Department , Parc Taul\u00ed Hospital Universitari, Institut d\u2019Investigaci\u00f3 i Innovaci\u00f3 Parc Taul\u00ed I3PT , Universitat Aut\u00f2noma de Barcelona , Sabadell , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2017,8,1]]},"reference":[{"key":"2021021300552364125_j_cclm-2017-0441_ref_001_w2aab3b7d103b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Mul\u00e9 SJ, Casella GA. Confirmation and quantitation of barbiturates in human urine by gas chromatography\/mass spectrometry. J Anal Toxicol 1989;13:13\u20136.","DOI":"10.1093\/jat\/13.1.13"},{"key":"2021021300552364125_j_cclm-2017-0441_ref_002_w2aab3b7d103b1b6b1ab2b1b2Aa","unstructured":"National Center for Biotechnology Information. PubChem Compound Database Ethosuximide. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/3291. Accessed March 2017."},{"key":"2021021300552364125_j_cclm-2017-0441_ref_003_w2aab3b7d103b1b6b1ab2b1b3Aa","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios (AEMPS). Ministerio de Sanidad, Asuntos sociales e Igualdad. Etosuximida FAES 250 mg. https:\/\/www.aemps.gob.es\/cima\/dochtml\/p\/42250\/Prospecto_42250.html. Accessed March 2017."},{"key":"2021021300552364125_j_cclm-2017-0441_ref_004_w2aab3b7d103b1b6b1ab2b1b4Aa","unstructured":"L\u00f3pez Mart\u00ednez R, Alonso Nieva N, Serrat Or\u00fas N, Gella Tom\u00e1s FJ, Boned Juliani B, Canalias Reverter F, et al. Procedimiento para el estudio de la interferencia por hem\u00f3lisis, bilirrubina y turbidez y para la verificaci\u00f3n de los \u00edndices de hem\u00f3lisis, ictericia y lipemia. Available from: http:\/\/www.seqc.es\/es\/comisiones\/comision-demetrologia-y-sistemas-analiticos\/_id:18\/ (Sociedad Espa\u00f1ola de Medicina de Laboratorio, SEQC). Accessed July 2017."},{"key":"2021021300552364125_j_cclm-2017-0441_ref_005_w2aab3b7d103b1b6b1ab2b1b5Aa","unstructured":"Mc.Enroe RJ, Burritt MJ, Powers DM, Rheinheimer DW, Wallace BH. Interference testing in clinical chemistry. Approved Guideline, 2nd ed. Clinical and Laboratory Standards Institute. Available from: http:\/\/shop.clsi.org. Accessed July 2013."}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2018.56.issue-2\/cclm-2017-0441\/cclm-2017-0441.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0441\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0441\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:58:28Z","timestamp":1619049508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0441\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,1]]},"references-count":5,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,8,1]]},"published-print":{"date-parts":[[2018,1,26]]}},"alternative-id":["10.1515\/cclm-2017-0441"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2017-0441","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,1]]}}}